Heartbeam Warrant Stock EBITDA
| BEATW Stock | USD 0.82 0.02 2.50% |
Heartbeam Warrant fundamentals help investors to digest information that contributes to Heartbeam Warrant's financial success or failures. It also enables traders to predict the movement of Heartbeam Stock. The fundamental analysis module provides a way to measure Heartbeam Warrant's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heartbeam Warrant stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 675 K | 641.2 K |
Heartbeam | EBITDA |
Heartbeam Warrant Company EBITDA Analysis
Heartbeam Warrant's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Heartbeam Warrant EBITDA | 675 K |
Most of Heartbeam Warrant's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heartbeam Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Heartbeam EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Heartbeam Warrant is extremely important. It helps to project a fair market value of Heartbeam Stock properly, considering its historical fundamentals such as EBITDA. Since Heartbeam Warrant's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heartbeam Warrant's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heartbeam Warrant's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Heartbeam Ebitda
Ebitda |
|
According to the company disclosure, Heartbeam Warrant reported earnings before interest,tax, depreciation and amortization of 675 K. This is 99.92% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 99.98% higher than that of the company.
Heartbeam EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heartbeam Warrant's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heartbeam Warrant could also be used in its relative valuation, which is a method of valuing Heartbeam Warrant by comparing valuation metrics of similar companies.Heartbeam Warrant is currently under evaluation in ebitda category among its peers.
Heartbeam Fundamentals
| Return On Equity | -1.64 | ||||
| Return On Asset | -0.9 | ||||
| Number Of Shares Shorted | 1.4 K | ||||
| EBITDA | 675 K | ||||
| Net Income | (14.64 M) | ||||
| Total Debt | 1.19 M | ||||
| Book Value Per Share | 0.30 X | ||||
| Cash Flow From Operations | (12.09 M) | ||||
| Earnings Per Share | (0.49) X | ||||
| Number Of Employees | 15 | ||||
| Total Asset | 17.13 M | ||||
| Retained Earnings | (36.83 M) | ||||
| Working Capital | 15.63 M | ||||
| Net Asset | 17.13 M |
About Heartbeam Warrant Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heartbeam Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heartbeam Warrant using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heartbeam Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Heartbeam Stock Analysis
When running Heartbeam Warrant's price analysis, check to measure Heartbeam Warrant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam Warrant is operating at the current time. Most of Heartbeam Warrant's value examination focuses on studying past and present price action to predict the probability of Heartbeam Warrant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam Warrant's price. Additionally, you may evaluate how the addition of Heartbeam Warrant to your portfolios can decrease your overall portfolio volatility.